# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3804653 | B | Inhibition of GST-tagged human recombinant wild type LRRK2 using fluorescein- ERM as substrate after 1 hr by TR-FRET assay | Homo sapiens | 49 | ALA3797078 | single protein format | Scientific Literature | |
2. | ALA3804654 | B | Inhibition of human recombinant LRRK2 G2019S mutant using fluorescein- ERM as substrate after 1 hr by TR-FRET assay | Homo sapiens | 50 | ALA3797078 | single protein format | Scientific Literature | |
3. | ALA3804655 | A | Plasma clearance in rat at 2 mg/kg, iv | Rattus norvegicus | 5 | ALA3797078 | organism-based format | Scientific Literature | |
4. | ALA3802081 | A | Half life in rat at 2 mg/kg, iv | Rattus norvegicus | 5 | ALA3797078 | organism-based format | Scientific Literature | |
5. | ALA3802082 | A | Oral bioavailability in rat at 10 mg/kg | Rattus norvegicus | 5 | ALA3797078 | organism-based format | Scientific Literature | |
6. | ALA3802083 | A | Cmax in rat at 10 mg/kg, po | Rattus norvegicus | 5 | ALA3797078 | organism-based format | Scientific Literature | |
7. | ALA3802084 | A | AUC in rat at 10 mg/kg, po | Rattus norvegicus | 5 | ALA3797078 | organism-based format | Scientific Literature | |
8. | ALA3802085 | A | Plasma concentration in rat at 5 mg/kg, ip after 1 hr | Rattus norvegicus | 5 | ALA3797078 | organism-based format | Scientific Literature | |
9. | ALA3802086 | A | Drug uptake in CSF in rat at 5 mg/kg, ip after 1 hr | Rattus norvegicus | 5 | ALA3797078 | organism-based format | Scientific Literature | |
10. | ALA3802087 | A | Intrinsic clearance in rat | Rattus norvegicus | 4 | ALA3797078 | organism-based format | Scientific Literature |